BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16775616)

  • 1. Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.
    Cella G; Marchetti M; Vignoli A; Randi ML; Saggiorato G; Pasetto L; Pagnan A; Barbui T; Falanga A
    Leukemia; 2006 Aug; 20(8):1430-4. PubMed ID: 16775616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.
    Falanga A; Marchetti M; Evangelista V; Manarini S; Oldani E; Giovanelli S; Galbusera M; Cerletti C; Barbui T
    Blood; 1999 Apr; 93(8):2506-14. PubMed ID: 10194429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
    Karadogan C; Karadogan I; Bilgin AU; Undar L
    Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Martino M; Minciullo PL; Saija A; Gangemi S
    Transfus Med; 2005 Oct; 15(5):425-8. PubMed ID: 16202058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of factors for poor mobilization after administration of recombinant human granulocyte stimulating factor (rHuG-CSF) in healthy donors].
    Aoyama Y; Nakamae H; Yamamura R; Makita K; Shima E; Hasegawa T; Sakamoto C; Kho G; Ohta K; Yamane T; Takubo T; Hino M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):829-36. PubMed ID: 12852351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Cimino F; Martino M; Minciullo PL; Calabrò C; Saija A; Gangemi S
    Transfus Apher Sci; 2005 Oct; 33(2):141-6. PubMed ID: 16103013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression.
    Rutella S; Rumi C; Pierelli L; Morosetti R; Sica S; Bonanno G; Scambia G; Leone G
    Exp Hematol; 2000 Jun; 28(6):612-25. PubMed ID: 10880747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
    Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
    Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantation.
    Stoppa AM; Blaise D; Viens P; Baume D; Mannoni P; Novakovitch G; David FA; Yver A; Maraninchi D
    Bone Marrow Transplant; 1994 May; 13(5):541-7. PubMed ID: 7519936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rhG-CSF plus dexamethasone on hemostatic parameters in healthy granulocyte donors: role of u-PA and nitric oxide.
    Ekmekçi OB; Oztürk G; Ekmekçi H; Atay D; Yanaşik M; Anak S; Devecioğlu O
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):689-94. PubMed ID: 18544592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo expansion of the circulating stem cell pool.
    Körbling M
    Stem Cells; 1998; 16 Suppl 1():131-8. PubMed ID: 11012155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation.
    Geissler K; Harrington M; Srivastava C; Leemhuis T; Tricot G; Broxmeyer HE
    J Immunol; 1989 Jul; 143(1):140-6. PubMed ID: 2471733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.